Digbi Health operates a national telehealth platform that uses precision biology—genetics, gut microbiome, advanced blood markers, and AI—to treat the metabolic and inflammatory illnesses that impact longevity using personalized Food-as-Medicine and pharma (GLP-1, HRT). We exclusively partner with major insurers and employers to make care broadly accessible while advancing the science through ongoing studies with leading pharmaceutical companies and medical schools, including Stanford and Northwestern Medical.